{"id":"https://openalex.org/W2000505839","doi":"https://doi.org/10.1016/j.critrevonc.2009.12.003","title":"Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO)","display_name":"Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO)","alternate_titles":[],"publication_year":2010,"publication_date":"2010-03-31","ids":{"openalex":"https://openalex.org/W2000505839","doi":"https://doi.org/10.1016/j.critrevonc.2009.12.003","mag":"2000505839","pmid":"https://pubmed.ncbi.nlm.nih.gov/20356760"},"language":"en","primary_location":{"id":"doi:10.1016/j.critrevonc.2009.12.003","doi":"https://doi.org/10.1016/j.critrevonc.2009.12.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.critrevonc.2009.12.003","pdf_url":null,"source":{"id":"https://openalex.org/S185233701","display_name":"Critical Reviews in Oncology/Hematology","issn_l":"1040-8428","issn":["1040-8428","1879-0461"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews in Oncology/Hematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000505839"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078533276","display_name":"Fr\u00e9d\u00e9rique Rousseau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150365","display_name":"Institut Paoli-Calmettes","ror":"https://ror.org/04s3t1g37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210150365"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"F. Rousseau","raw_affiliation_strings":["Pilot Unit of Research and Coordination in Geriatric Oncology, Department of Medicine, Institut PAOLI CALMETTES, 232 Bd Sainte Marguerite,13273 Marseille Cedex 9, France. rousseauf@marseille.fnclcc.fr","Pilot Unit of Research and Coordination in Geriatric Oncology, Department of Medicine, Institut PAOLI CALMETTES, 232 Bd Sainte Marguerite,13273 Marseille Cedex 9, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pilot Unit of Research and Coordination in Geriatric Oncology, Department of Medicine, Institut PAOLI CALMETTES, 232 Bd Sainte Marguerite,13273 Marseille Cedex 9, France. rousseauf@marseille.fnclcc.fr","institution_ids":["https://openalex.org/I4210150365"]},{"raw_affiliation_string":"Pilot Unit of Research and Coordination in Geriatric Oncology, Department of Medicine, Institut PAOLI CALMETTES, 232 Bd Sainte Marguerite,13273 Marseille Cedex 9, France","institution_ids":["https://openalex.org/I4210150365"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016809605","display_name":"F. R\u00e9tornaz","orcid":"https://orcid.org/0000-0002-4997-1487","observed_orcids":["https://orcid.org/0000-0002-4997-1487"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Retornaz","raw_affiliation_strings":["Pilot Unit of Research and Coordination in Geriatric Oncology, Departmental Gerontologic Centre, 1 rue Elz\u00e9ard Rougier, 13012 Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pilot Unit of Research and Coordination in Geriatric Oncology, Departmental Gerontologic Centre, 1 rue Elz\u00e9ard Rougier, 13012 Marseille, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042461515","display_name":"Florence Joly","orcid":"https://orcid.org/0000-0001-7004-9895","observed_orcids":["https://orcid.org/0000-0001-7004-9895","https://orcid.org/0000-0001-6168-4942"]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F. Joly","raw_affiliation_strings":["Centre Fran\u00e7ois Baclesse, Avenue du g\u00e9n\u00e9ral Harris, 14076 Caen Cedex 5, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Fran\u00e7ois Baclesse, Avenue du g\u00e9n\u00e9ral Harris, 14076 Caen Cedex 5, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072330852","display_name":"Benjamin Esterni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110881","display_name":"Centre Eug\u00e8ne Marquis","ror":"https://ror.org/01yezas83","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210110881"]},{"id":"https://openalex.org/I4210150365","display_name":"Institut Paoli-Calmettes","ror":"https://ror.org/04s3t1g37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210150365"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B. Esterni","raw_affiliation_strings":["Centre Eug\u00e8ne Marquis, 35 rue de la Bataille Flandres Dunkerque, 35042 Rennes, France","Department of Clinical Study and Biostatistics, Institut PAOLI CALMETTES, 232 Bd Sainte Marguerite, 13273 Marseille Cedex 9, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Eug\u00e8ne Marquis, 35 rue de la Bataille Flandres Dunkerque, 35042 Rennes, France","institution_ids":["https://openalex.org/I4210110881"]},{"raw_affiliation_string":"Department of Clinical Study and Biostatistics, Institut PAOLI CALMETTES, 232 Bd Sainte Marguerite, 13273 Marseille Cedex 9, France","institution_ids":["https://openalex.org/I4210150365"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040171322","display_name":"Sophie Abadie\u2010Lacourtoisie","orcid":"https://orcid.org/0009-0000-5886-3018","observed_orcids":["https://orcid.org/0009-0000-5886-3018"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Abadie-Lacourtoisie","raw_affiliation_strings":["Centre Paul Papin, 2 rue Moll, 49033 Angers Cedex 01, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Paul Papin, 2 rue Moll, 49033 Angers Cedex 01, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038734791","display_name":"Pierre Fargeot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Fargeot","raw_affiliation_strings":["Centre Georges Fran\u00e7ois Leclerc, 1 rue du Professeur Marion, 21034 Dijon Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Georges Fran\u00e7ois Leclerc, 1 rue du Professeur Marion, 21034 Dijon Cedex, France","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111839911","display_name":"\u00c9. Luporsi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Luporsi","raw_affiliation_strings":["Centre Alexis Vautrin, Avenue de Bourgogne RN 74 Brabois, 54511 Vandeuvre les Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Alexis Vautrin, Avenue de Bourgogne RN 74 Brabois, 54511 Vandeuvre les Nancy, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091800070","display_name":"V. Servent","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131356","display_name":"Centre Oscar Lambret","ror":"https://ror.org/03xfq7a50","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210131356","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"V. Servent","raw_affiliation_strings":["Centre Oscar Lambret, 3 rue F. Combermale, 59000 Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Oscar Lambret, 3 rue F. Combermale, 59000 Lille, France","institution_ids":["https://openalex.org/I4210131356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021549650","display_name":"Brigitte Laguerre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110881","display_name":"Centre Eug\u00e8ne Marquis","ror":"https://ror.org/01yezas83","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210110881"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B. Laguerre","raw_affiliation_strings":["Centre Eug\u00e8ne Marquis, 35 rue de la Bataille Flandres Dunkerque, 35042 Rennes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Eug\u00e8ne Marquis, 35 rue de la Bataille Flandres Dunkerque, 35042 Rennes, France","institution_ids":["https://openalex.org/I4210110881"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005973748","display_name":"Etienne G.C. Brain","orcid":"https://orcid.org/0000-0003-0881-9371","observed_orcids":["https://orcid.org/0000-0003-0881-9371"]},"institutions":[{"id":"https://openalex.org/I4210116453","display_name":"H\u00f4pital Ren\u00e9 Huguenin","ror":"https://ror.org/0263jp665","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210116453"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Brain","raw_affiliation_strings":["Centre Ren\u00e9 Huguenin, 35 rue Dailly, 92211 Saint Cloud Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Ren\u00e9 Huguenin, 35 rue Dailly, 92211 Saint Cloud Cedex, France","institution_ids":["https://openalex.org/I4210116453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013166168","display_name":"Jean Gen\u00e8ve","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Geneve","raw_affiliation_strings":["Geriatric Oncology Group of the F\u00e9d\u00e9ration Nationale des Centres de Lutte Contre le Cancer (FNCLCC), 101, rue de Tolbiac, 75654 Paris Cedex 13, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geriatric Oncology Group of the F\u00e9d\u00e9ration Nationale des Centres de Lutte Contre le Cancer (FNCLCC), 101, rue de Tolbiac, 75654 Paris Cedex 13, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5078533276"],"corresponding_institution_ids":["https://openalex.org/I4210150365"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":null,"fwci":1.4662,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.82390608,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"76","issue":"1","first_page":"71","last_page":"78"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11011","display_name":"Frailty in Older Adults","score":0.8320000171661377,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11011","display_name":"Frailty in Older Adults","score":0.8320000171661377,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10397","display_name":"Nutrition and Health in Aging","score":0.07639999687671661,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.014600000344216824,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9789999723434448},{"id":"https://openalex.org/keywords/vinorelbine","display_name":"vinorelbine","score":1.0},{"id":"https://openalex.org/keywords/oral-chemotherapy","display_name":"oral chemotherapy","score":0.7839999794960022},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.7910000085830688},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8489999771118164},{"id":"https://openalex.org/keywords/functional-status","display_name":"functional status","score":0.9549999833106995},{"id":"https://openalex.org/keywords/activities-of-daily-living","display_name":"activities of daily living","score":0.9980000257492065},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.6830000281333923},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7799999713897705},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8460000157356262},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.984000027179718},{"id":"https://openalex.org/keywords/geriatric-oncology","display_name":"geriatric oncology","score":0.9160000085830688}],"concepts":[{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.9071078300476074},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.8878127932548523},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8674323558807373},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6966619491577148},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5638130903244019},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.5599619746208191},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4747127592563629},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3593534231185913},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.18192878365516663},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000069287","descriptor_name":"Capecitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077235","descriptor_name":"Vinorelbine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.critrevonc.2009.12.003","doi":"https://doi.org/10.1016/j.critrevonc.2009.12.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.critrevonc.2009.12.003","pdf_url":null,"source":{"id":"https://openalex.org/S185233701","display_name":"Critical Reviews in Oncology/Hematology","issn_l":"1040-8428","issn":["1040-8428","1879-0461"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews in Oncology/Hematology","raw_type":"journal-article"},{"id":"pmid:20356760","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20356760","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical reviews in oncology/hematology","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1531502848","https://openalex.org/W1550111394","https://openalex.org/W1978229612","https://openalex.org/W1984073388","https://openalex.org/W2006318999","https://openalex.org/W2015693618","https://openalex.org/W2021499511","https://openalex.org/W2038793941","https://openalex.org/W2044970916","https://openalex.org/W2049433896","https://openalex.org/W2063861120","https://openalex.org/W2099199992","https://openalex.org/W2106804959","https://openalex.org/W2108729453","https://openalex.org/W2109057413","https://openalex.org/W2115931762","https://openalex.org/W2118363110","https://openalex.org/W2120748666","https://openalex.org/W2131139696","https://openalex.org/W2131770017","https://openalex.org/W2137009016","https://openalex.org/W2141258726","https://openalex.org/W2144025679","https://openalex.org/W2144266865","https://openalex.org/W2147839112","https://openalex.org/W2167014559","https://openalex.org/W2213973060","https://openalex.org/W2274864274"],"related_works":["https://openalex.org/W1251908816","https://openalex.org/W2054707889","https://openalex.org/W2512874285","https://openalex.org/W2287561065","https://openalex.org/W2411296410","https://openalex.org/W2183047580","https://openalex.org/W2010206423","https://openalex.org/W2151387711","https://openalex.org/W2130156789","https://openalex.org/W2034185054"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000505839","counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
